Exclusive - CVC and Temasek to buy $2 billion generic drugs firm Alvogen
0
LONDON (Reuters) - European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said.